Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Therapy for Postreperfusion Hyperglycemia in Liver Transplantation
NCT03152890Phase 4Recruiting
- Sponsor
- Seoul National University Hospital
- Start
- May 2017
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of human insulin in hyperglycemia, sponsored by Seoul National University Hospital. Primary endpoint: Change of blood glucose level. Started May 2017; status: recruiting.
02
Drugs
human insulin
03
Conditions
hyperglycemia
Beyond the preview
Go deeper on NCT03152890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03152890.